JPMorgan Value Advantage Fund
JVAAX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- JPMorgan Value Advantage Fund (JVAAX) is an open-end mutual fund managed by J.P. Morgan Investment Management Inc. that seeks long-term total return primarily through a portfolio of attractively valued U.S. equity securities across all market capitalizations, including large-, mid- and small-cap common stocks and real estate investment trusts (REITs); it employs a bottom-up stock selection process based on proprietary fundamental analysis to identify undervalued companies with potential to grow intrinsic value per share. The fund offers multiple share classes, including A shares (JVAAX) with a 5.25% front-end load and minimum initial investment of $1,000, C shares (JVACX), I shares (JVASX), L shares (JVAIX), and R-series shares (JGAQX, JVAPX, JVAQX, JVARX, JVAYX), with net expense ratios ranging from 0.74% for I shares to 0.99% for A shares after contractual waivers through October 31, 2025. As of September 30, 2025, the fund manages approximately $9.06 billion in assets, with a portfolio of around 129 holdings, a weighted average market capitalization of $164 billion, a forward P/E ratio of 15.45, and top sectors including financials (27.1%), health care (15.3%), and consumer discretionary (9.0%); top holdings feature Wells Fargo & Co. (3.6%), Berkshire Hathaway Inc. Class B (2.9%), and Bank of America Corp. (1.9%). Launched on February 28, 2005, and domiciled in the United States, the fund targets individual and institutional investors seeking exposure to the large value Morningstar category through an all-cap value approach benchmarked against the Russell 3000 Value Index. In a significant management transition effective July 2024, Scott Blasdell, with 31 years of experience, assumed the lead portfolio manager role from longtime manager Jonathan Simon, who retired in early 2025, while comanager Graham Spence, with 23 years of experience and ties to the prior regime, continues to support alongside Blasdell's large-cap analyst team and the firm's small/mid value analysts; this shift introduces a more sector-agnostic allocation strategy focused on best value opportunities, potentially increasing portfolio turnover from historical levels of 15-30% while maintaining a quality bias and value discipline. Amid 2025 market volatility in Q1-Q2, including tariff concerns and regulatory shifts, the management team opportunistically adjusted holdings by adding to secular winners facing cyclical headwinds, eliminating lower-conviction positions, increasing portfolio beta modestly, and overweighting financials and health care at discounted valuations to capitalize on improved M&A activity, capital returns, loan origination, and earnings tailwinds. The fund remains available primarily to U.S. investors through platforms like Schwab and Fidelity, with no reported acquisitions, funding rounds, or structural reorganizations in the past two years.